IKKα controls formation of the epidermis independently of NF-κB

被引:292
|
作者
Hu, YL [1 ]
Baud, V [1 ]
Oga, T [1 ]
Kim, KII [1 ]
Yoshida, K [1 ]
Karin, M [1 ]
机构
[1] Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
关键词
D O I
10.1038/35070605
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The IKK alpha and IKK beta catalytic subunits of I kappaB kinase (IKK) share 51% amino-acid identity and similar biochemical activities: they both phosphorylate I kappaB proteins at serines that trigger their degradation(1-4). IKK alpha and IKK beta differ, however, in their physiological functions. IKK beta and the IKK gamma /NEMO regulatory subunit are required for activating NF-kappaB by pro-inflammatory stimuli and preventing apoptosis induced by tumour necrosis factor-alpha (refs 5-11). IKK alpha is dispensable for these functions, but is essential for developing the epidermis and its derivatives(12-15). The mammalian epidermis is composed of the basal, spinous, granular and cornified layers(16). Only basal keratinocytes can proliferate and give rise to differentiated derivatives, which on full maturation undergo enucleation to generate the cornified layer. Curiously, keratinocyte-specific inhibition of NF-kappaB, as in Ikk alpha (-/-) mice(12-15), results in epidermal thickening but does not block terminal differentiation(17,18). It has been proposed(19,20) that the epidermal defect in Ikk alpha (-/-) mice may be due to the failed activation of NF-kappaB. Here we show that the unique function of IKK alpha in control of keratinocyte differentiation is not exerted through its I kappaB kinase activity or through NF-kappaB. Instead, IKK alpha controls production of a soluble factor that induces keratinocyte differentiation.
引用
收藏
页码:710 / 714
页数:5
相关论文
共 50 条
  • [31] The IKK complex:: an integrator of all signals that activate NF-κB?
    Israël, A
    TRENDS IN CELL BIOLOGY, 2000, 10 (04) : 129 - 133
  • [32] The IKK NF-κB system: a treasure trove for drug development
    Michael Karin
    Yumi Yamamoto
    Q. May Wang
    Nature Reviews Drug Discovery, 2004, 3 : 17 - 26
  • [33] The role of IKKβ/NF-κB pathway in the pathogenesis of heart failure
    Hikoso, Shungo
    Otsu, Kinya
    Hori, Masatsugu
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 : S31 - S32
  • [34] IKK- and NF-κB-Mediated Functions in Carcinogenesis
    Arkan, Melek C.
    Greten, Florian R.
    NF-KB IN HEALTH AND DISEASE, 2011, 349 : 159 - 169
  • [35] CSN controls NF-κB by deubiquitinylation of IκBα
    Schweitzer, Katrin
    Bozko, Przemyslaw M.
    Dubiel, Wolfgang
    Naumann, Michael
    EMBO JOURNAL, 2007, 26 (06): : 1532 - 1541
  • [36] Distinct roles for IKK1 and IKK2 in the activation of NF-κB.
    O'Mahony, A
    Montano, M
    Greene, WC
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 : S72 - S72
  • [37] The IκB kinase (IKK) and NF-κB:: key elements of proinflammatory signalling
    Karin, M
    Delhase, M
    SEMINARS IN IMMUNOLOGY, 2000, 12 (01) : 85 - 98
  • [38] NF-κB, IκB, and IKK: Integral Components of Immune System Signaling
    Mulero, Maria Carmen
    Huxford, Tom
    Ghosh, Gourisankar
    STRUCTURAL IMMUNOLOGY, 2019, 1172 : 207 - 226
  • [39] How NF-κB is activated: the role of the IκB kinase (IKK) complex
    Michael Karin
    Oncogene, 1999, 18 : 6867 - 6874
  • [40] How NF-κB is activated:: the role of the IκB kinase (IKK) complex
    Karin, M
    ONCOGENE, 1999, 18 (49) : 6867 - 6874